arsenic has been researched along with zidovudine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bazarbachi, A; Hermine, O | 1 |
| Arnulf, B; Bazarbachi, A; Brouet, JC; Damaj, G; de Thé, H; Degos, L; Delarue, R; Dombret, H; Fermand, JP; Hermine, O; Lefrère, F; Poupon, J; Rousselot, P; Varet, B | 1 |
| Correa, R; Mangeat, B; Piguet, V; Pion, M; Stalder, R; Towers, GJ | 1 |
| Augustyniak, C; Evens, AM; Gordon, LI; Gupta, R; Mehta, J; Ziegler, SL | 1 |
| Bazarbachi, A; de Thé, H; El Hajj, H; Farid, R; Hatoum, H; Hermine, O; Kchour, G; Kooshyar, MM; Mahmoudi, M; Maleki, M; Rafatpanah, H; Rahimi, H; Rezaee, SA; Shirdel, A; Tarhini, M; Wattel, E; Yazdi, MT | 1 |
| Gessain, A; Mahieux, R | 1 |
| Chen, C; Huang, D; Qi, Y; Wang, Y; Xi, Y; Zhang, Y | 1 |
| Gallo, RC | 1 |
| Alimoghaddam, K; Bashash, D; Ghaffari, SH; Ghavamzadeh, A; Hassani, S; Mardani, H; Mirzaee, R; Yousefi, M; Zaghal, A; Zaker, F; Zekri, A | 1 |
| Bazarbachi, A; Berry, F; Dassouki, Z; de Thé, H; El Hajj, H; Ezzedine, M; Farid, R; Ghantous, A; Ghavamzadeh, A; Hermine, O; Kchour, G; Kooshyar, MM; Mahmoudi, M; Mortada, M; Nasser, R; Rafatpanah, H; Rahimi, H; Rezaee, R; Shirdel, A; Tarhini, M | 1 |
| Bazarbachi, A; Hermine, O; Marçais, A; Nasr, R | 1 |
4 review(s) available for arsenic and zidovudine
| Article | Year |
|---|---|
Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Arsenic Trioxide; Arsenicals; Bone Marrow Transplantation; Combined Modality Therapy; Drug Therapy, Combination; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Oxides; Retinoids; Tumor Virus Infections; Zidovudine | 2001 |
Adult T-cell leukemia/lymphoma and HTLV-1.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; CD4-Positive T-Lymphocytes; Clinical Trials as Topic; Daclizumab; Drug Resistance, Neoplasm; Endemic Diseases; Female; Gene Products, tax; Genes, pX; Human T-lymphotropic virus 1; Humans; Immunoglobulin G; Immunophenotyping; Immunotherapy; Infant, Newborn; Infectious Disease Transmission, Vertical; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Oxides; Paraparesis, Tropical Spastic; Pregnancy; Pregnancy Complications, Infectious; Zidovudine | 2007 |
Research and discovery of the first human cancer virus, HTLV-1.
Topics: Adult; Animals; Antiviral Agents; Arsenic; Cell Proliferation; Cell Transformation, Viral; Host-Pathogen Interactions; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Interferons; Leukemia-Lymphoma, Adult T-Cell; Mice; Mice, Transgenic; Viral Proteins; Virus Replication; Zidovudine | 2011 |
Overview of Targeted Therapies for Adult T-Cell Leukemia/Lymphoma.
Topics: Adult; Antineoplastic Agents, Immunological; Arsenic Trioxide; Arsenicals; Female; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Oxides; Receptors, CXCR4; Zidovudine | 2017 |
2 trial(s) available for arsenic and zidovudine
| Article | Year |
|---|---|
Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma.
Topics: Adult; Anti-HIV Agents; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Female; Human T-lymphotropic virus 1; Humans; Injections, Intravenous; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Oxides; Prognosis; Recurrence; Treatment Outcome; Zidovudine | 2004 |
Phase 2 study of the efficacy and safety of the combination of arsenic trioxide, interferon alpha, and zidovudine in newly diagnosed chronic adult T-cell leukemia/lymphoma (ATL).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Chemical and Drug Induced Liver Injury; Drug Eruptions; Drug Synergism; Female; Gastrointestinal Diseases; Hematologic Diseases; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Oxides; Proviruses; Remission Induction; Viral Load; Zidovudine | 2009 |
5 other study(ies) available for arsenic and zidovudine
| Article | Year |
|---|---|
Identification of an arsenic-sensitive block to primate lentiviral infection of human dendritic cells.
Topics: Antiviral Agents; Antiviral Restriction Factors; APOBEC-3G Deaminase; Arsenic; Arsenic Trioxide; Arsenicals; Carrier Proteins; CD4-Positive T-Lymphocytes; Cell Lineage; Cytidine Deaminase; Dendritic Cells; Gene Expression Regulation, Viral; HeLa Cells; HIV-1; Humans; Lentivirus; Lentivirus Infections; Oxides; Tripartite Motif Proteins; Ubiquitin-Protein Ligases; Zidovudine | 2007 |
Sustained hematologic and central nervous system remission with single-agent denileukin diftitox in refractory adult T-cell leukemia/lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Bone Marrow Transplantation; Central Nervous System Neoplasms; Diphtheria Toxin; Drug Resistance, Neoplasm; Hematologic Neoplasms; Humans; Interferons; Interleukin-2; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Oxides; Recombinant Fusion Proteins; Recurrence; Remission Induction; Transplantation, Homologous; Zidovudine | 2007 |
Synergic effect of 3'-azido-3'-deoxythymidine and arsenic trioxide in suppressing hepatoma cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Antitubercular Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Caspase 3; Cell Growth Processes; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Hep G2 Cells; Humans; Liver Neoplasms; Mice; Mice, Inbred BALB C; Oxides; Telomerase; Xenograft Model Antitumor Assays; Zidovudine | 2011 |
Azidothymidine hinders arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells by induction of p21 and attenuation of G2/M arrest.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; G2 Phase Cell Cycle Checkpoints; Humans; Leukemia, Promyelocytic, Acute; M Phase Cell Cycle Checkpoints; Oxides; Zidovudine | 2013 |
The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma.
Topics: Adult; Aged; Arsenic Trioxide; Arsenicals; Cytokines; Female; Gene Expression Profiling; HTLV-I Infections; Humans; Immunologic Factors; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Oxides; Prospective Studies; Treatment Outcome; Zidovudine | 2013 |